相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy regulates long-term cross-presentation by murine dendritic cells
Nataschja I. Ho et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
Thomas Hueso et al.
BONE MARROW TRANSPLANTATION (2020)
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Jaime Sanz et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Haploidentical- versus identical-sibling transplant for high-risk pediatric AML: A multi-center study
Feng-Mei Zheng et al.
CANCER COMMUNICATIONS (2020)
Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling
Wenzhuo Ma et al.
ACTA PHYSIOLOGICA (2020)
Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3
Megan S. Molina et al.
FRONTIERS IN IMMUNOLOGY (2020)
T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies
Emmanuel Katsanis et al.
FRONTIERS IN PEDIATRICS (2020)
Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia
Jessica Stokes et al.
ONCOIMMUNOLOGY (2020)
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells
Jilu Zhang et al.
LEUKEMIA (2019)
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
Alexandra Gomez-Arteaga et al.
BONE MARROW TRANSPLANTATION (2019)
FMS-LIKE TYROSINE KINASE 3/FLT3: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Julhash U. Kazi et al.
PHYSIOLOGICAL REVIEWS (2019)
Graft-Versus Host Disease Prophylaxis with Postransplantation Bendamustine in Refractory Leaukemia Patients
Ivan S. Moiseev et al.
BLOOD (2019)
Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells
Jessica Stokes et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Developing role of B cells in the pathogenesis and treatment of chronic GVHD
Xiaoping Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells
Masaaki Hotta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience
Khalil Saleh et al.
LEUKEMIA & LYMPHOMA (2018)
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers
Sylvain P. Chantepie et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies
Emmanuel Katsanis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD
Kate A. Markey et al.
CLINICAL CANCER RESEARCH (2018)
Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation
Scott S. Graves et al.
ILAR JOURNAL (2018)
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C. Betts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL
I. F. Khouri et al.
BONE MARROW TRANSPLANTATION (2017)
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Catherine J. Lee et al.
HAEMATOLOGICA (2017)
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
Qian Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Catherine J. Lee et al.
HAEMATOLOGICA (2017)
Inhibition of STAT3 by Anticancer Drug Bendamustine
Kazunori Iwamoto et al.
PLOS ONE (2017)
A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation
K. Riesner et al.
BONE MARROW TRANSPLANTATION (2016)
Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
Robert Zeiser et al.
BLOOD (2016)
A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy
M. Martino et al.
BONE MARROW TRANSPLANTATION (2016)
Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation
Jessica Stokes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Bendamustine increases interleukin-10 secretion from B cells via p38 MAP kinase activation
Le Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide
Fan Yang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Circulating CD14+HLA-DR-/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease
Jin Yin et al.
CANCER MEDICINE (2016)
Host CD8α+Dendritic Cells May Be a Key Factor for Separating Graft-versus-Host Disease from Graft-versus-Leukemia
Tomomi Toubai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity
Joanna J. Messmann et al.
BLOOD (2015)
Next generation HLA-haploidentical HSCT
M. F. Martelli et al.
BONE MARROW TRANSPLANTATION (2015)
HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
E. J. Fuchs
BONE MARROW TRANSPLANTATION (2015)
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update
A. Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2015)
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease
Antonio Pierini et al.
JOURNAL OF IMMUNOLOGY (2015)
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation
H. Nakasone et al.
BONE MARROW TRANSPLANTATION (2015)
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Stem Cells
Antonio Vendramin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Designed grafts for HLA-haploidentical stem cell transplantation
Massimo F. Martelli et al.
BLOOD (2014)
Haploidentical transplantation: the search for the best donor
Rupert Handgretinger
BLOOD (2014)
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
Sudipto Ganguly et al.
BLOOD (2014)
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza et al.
BLOOD (2014)
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD
Issa F. Khouri et al.
BLOOD (2014)
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma
Giuseppe Visani et al.
BLOOD (2014)
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma
A. Raiola et al.
BONE MARROW TRANSPLANTATION (2014)
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
L. Castagna et al.
BONE MARROW TRANSPLANTATION (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice
Dapeng Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial
Brian Kornblit et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Race and ethnicity in decisions about unrelated hematopoietic stem cell donation
Galen E. Switzer et al.
BLOOD (2013)
Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease
Doanh Le Huu et al.
BLOOD (2013)
Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34+ cells and a fixed CD3+ dose
C. C. Dvorak et al.
BONE MARROW TRANSPLANTATION (2013)
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and-DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization
J. Pidala et al.
BONE MARROW TRANSPLANTATION (2013)
Negative depletion of α/β+ T cells and of CD19+B lymphocytes: A novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation
Franco Locatelli et al.
IMMUNOLOGY LETTERS (2013)
Treatment and management of graft-versus-host disease: improving response and survival
Catherine Garnett et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
FTY720 Markedly Increases Alloengraftment but Does Not Eliminate Host Anti-Donor T Cells that Cause Graft Rejection on Its Withdrawal
Patricia A. Taylor et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan et al.
BLOOD (2012)
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
Birgit Federmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Donor B Cells in Transplants Augment Clonal Expansion and Survival of Pathogenic CD4+ T Cells That Mediate Autoimmune-like Chronic Graft-versus-Host Disease
James S. Young et al.
JOURNAL OF IMMUNOLOGY (2012)
Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine
Neil Beeharry et al.
PLOS ONE (2012)
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Leo Luznik et al.
SEMINARS IN ONCOLOGY (2012)
Advances in graft-versus-host disease biology and therapy
Bruce R. Blazar et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide
Ashley T. Munchel et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Giuseppe Visani et al.
BLOOD (2011)
Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel Therapies
Philippe Moreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Immunization with host-type CD8α+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner
Tomomi Toubai et al.
BLOOD (2010)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation
Leo Luznik et al.
IMMUNOLOGIC RESEARCH (2010)
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Marco Mielcarek et al.
BLOOD (2009)
Acute graft-versus-host disease: from the bench to the bedside
Gerard Socie et al.
BLOOD (2009)
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block
Varsha Gandhi et al.
CLINICAL CANCER RESEARCH (2009)
Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism
Young-Don Joo et al.
IMMUNOLOGY (2009)
Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Wolfgang U. Knauf et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Mouse models of bone marrow transplantation
Pavan Reddy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Vu H. Nguyen et al.
BLOOD (2008)
GVHD after chemotherapy conditioning in allogeneic transplanted mice
B. Sadeghi et al.
BONE MARROW TRANSPLANTATION (2008)
Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases
R. A. Brodsky et al.
BONE MARROW TRANSPLANTATION (2008)
Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents
Lorenzo M. Leoni et al.
CLINICAL CANCER RESEARCH (2008)
Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways
Leander Gaul et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Robert Zeiser et al.
BLOOD (2008)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
An essential role for Akt1 in dendritic cell function and tumor immunotherapy
Dongsu Park et al.
NATURE BIOTECHNOLOGY (2006)
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as patients conditioning regimens for undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission
DI Marks et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
PA Taylor et al.
BLOOD (2005)
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD
J Ermann et al.
BLOOD (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
Cytotoxic efficacy of bendamustine in human leukemia and breast cancer cell lines
SM Konstantinov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets
B Nikolic et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies
EP Alessandrino et al.
BONE MARROW TRANSPLANTATION (2000)
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
TM Cao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
分享论文
